These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38990487)

  • 1. ENTIMOS: Decision Support Tool Highlights Potential Impact of Non-intravenous Therapies for Multiple Sclerosis on Patient Care via Clinical Scenario Simulation.
    Nicholas R; Scalfaro E; Dorsey R; Angehrn Z; Banhazi J; Brennan R; Adlard N
    Pharmacoecon Open; 2024 Sep; 8(5):755-764. PubMed ID: 38990487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ENTIMOS: A Discrete Event Simulation Model for Maximising Efficiency of Infusion Suites in Centres Treating Multiple Sclerosis Patients.
    Lacinova K; Thokala P; Nicholas R; Dobay P; Scalfaro E; Angehrn Z; Brennan R; Boer I; Lines C; Adlard N
    Appl Health Econ Health Policy; 2022 Sep; 20(5):731-742. PubMed ID: 35585305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing an efficient scheduling template of a chemotherapy treatment unit: A case study.
    Ahmed Z; Elmekkawy T; Bates S
    Australas Med J; 2011; 4(10):575-88. PubMed ID: 23386870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficiency Model of Cladribine Tablets Versus Infusion-Based Disease-Modifying Drugs for Patients with Relapsing-Remitting Multiple Sclerosis.
    Tafazzoli A; Chavan A; Harty G; Moller J; Wong SL
    Adv Ther; 2020 Sep; 37(9):3791-3806. PubMed ID: 32647909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A discrete event simulation for improving operating theatre efficiency.
    Hassanzadeh H; Boyle J; Khanna S; Biki B; Syed F; Sweeney L; Borkwood E
    Int J Health Plann Manage; 2023 Mar; 38(2):360-379. PubMed ID: 36271501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing cost of intravenous infusion and subcutaneous biologics in COVID-19 pandemic care pathways for rheumatoid arthritis and inflammatory bowel disease: A brief UK stakeholder survey.
    Heald A; Bramham-Jones S; Davies M
    Int J Clin Pract; 2021 Sep; 75(9):e14341. PubMed ID: 33963659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Analysis of Subcutaneous vs Intravenous Administration of Natalizumab Based on Patient Care Pathway in Multiple Sclerosis in Spain.
    Alonso Torres AM; Arévalo Bernabé AG; Becerril Ríos N; Hellín Gil MF; Martínez Sesmero JM; Meca Lallana V; Ramió-Torrentà L; Rodríguez-Antigüedad A; Gómez Maldonado L; Triana Junco I; Gómez-Barrera M; Espinoza Cámac N; Oyagüez I
    Pharmacoecon Open; 2023 May; 7(3):431-441. PubMed ID: 36802327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling of hypothetical SARS-CoV-2 point of care tests for routine testing in residential care homes: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Jun; 25(39):1-74. PubMed ID: 34142943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-Routing Infliximab Therapy: Subcutaneous Infliximab Opens a Path Towards Greater Convenience and Clinical Benefit.
    Alten R; An Y; Kim DH; Yoon S; Peyrin-Biroulet L
    Clin Drug Investig; 2022 Jun; 42(6):477-489. PubMed ID: 35657560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Mar; 25(21):1-68. PubMed ID: 33764295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
    J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining the level of social distancing necessary to avoid future COVID-19 epidemic waves: a modelling study for North East London.
    Cheetham N; Waites W; Ebyarimpa I; Leber W; Brennan K; Panovska-Griffiths J
    Sci Rep; 2021 Mar; 11(1):5806. PubMed ID: 33707546
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.